CEFTOBIPROLE MEDOCARIL

Search structure
Status: Phase 3
Entry Type: Small molecule
Molecule Category: UNKNOWN
ATC: J01DI01
UNII: N99027V28J

Structure
InChI Key HFTSMHTWUFCYMJ-FDNJTQOMSA-N
Smile Cc1oc(=O)oc1COC(=O)N1CC[C@@H](N2CC/C(=C\C3=C(C(=O)O)N4C(=O)[C@@H](NC(=O)/C(=N/O)c5nsc(N)n5)[C@H]4SC3)C2=O)C1
InChI
InChI=1S/C26H26N8O11S2/c1-10-14(45-26(41)44-10)8-43-25(40)32-4-3-13(7-32)33-5-2-11(20(33)36)6-12-9-46-22-16(21(37)34(22)17(12)23(38)39)28-19(35)15(30-42)18-29-24(27)47-31-18/h6,13,16,22,42H,2-5,7-9H2,1H3,(H,28,35)(H,38,39)(H2,27,29,31)/b11-6+,30-15+/t13-,16-,22-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C26H26N8O11S2
Molecular Weight 690.67
AlogP -0.54
Hydrogen Bond Acceptor 16.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 8.0
Polar Surface Area 264.3
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 47.0

Indications

Mesh Heading Maximum Phase Reference
Bacteremia Phase 2 ClinicalTrials
Bacterial Infections; Communicable Diseases; Fever; Gram-Positive Bacterial Infections; Infection; Neutropenia; Pseudomonas Infections Phase 3 ClinicalTrials
Bacteremia Phase 3 ClinicalTrials
Meningitis Phase 2 ClinicalTrials
Healthcare-Associated Pneumonia; Pneumonia Phase 3 ClinicalTrials
Cellulitis; Communicable Diseases; Infection; Skin Diseases; Skin Diseases, Bacterial; Skin Diseases, Infectious; Staphylococcal Skin Infections Phase 3 ClinicalTrials
Pneumonia Phase 3 ClinicalTrials
Cellulitis; Communicable Diseases; Infection; Skin Diseases; Skin Diseases, Bacterial; Skin Diseases, Infectious; Staphylococcal Skin Infections Phase 3 ClinicalTrials
Communicable Diseases; Infection; Skin Diseases, Bacterial Phase 3 ClinicalTrials

Related Entries

MCS

Scaffolds

Cross References

Resources Reference
CAS NUMBER 376653-43-9
ChEMBL CHEMBL4297101
FDA SRS N99027V28J
PubChem 135413543
SureChEMBL SCHEMBL3069914
CAS NUMBER 376653-43-9
ChEMBL CHEMBL1652606
FDA SRS N99027V28J
PubChem 135413543
ZINC ZINC000072123798
CONTENTS